Fluctuating Capacity and Demand Conditions in Biomanufacturing

Publication
Article
BioPharm InternationalBioPharm International-10-15-2015
Volume 2015 eBook
Issue 2

BioPharm International eBooks

BioPharm International

eBooks Volume 28, Issue 14  

Contract manufacturing is a booming business, especially considering that many pharmaceutical companies-including those with a focus on biologic products- are no longer conducting much of their own research and development in-house. Fewer still are capable of scaling up from laboratory to commercial production without some type of outside help from a contract manufacturing organization (CMO).    Read this article and other articles in

BioPharm International

's 2015

The Future of Bioprocessing

eBook.
 

Articles in this issue
BP1015-Fluctuating.gif
Fluctuating Capacity and Demand Conditions in Biomanufacturing
BP1015-Cleaning.gif
Cleaning Validation for Biologics
BP1015-Automation.gif
Automation of Single-Use Systems
BP1015-Aseptic.gif
Aseptic Processing for Cytotherapy, Regenerative Medicine, and Tissue-Engineered Products
BP1015-Patent.gif
Are Biopharma Patents Poised on the Post-Grant Chopping Block?
BP1015-Innovations.gif
Innovations in Automation—High-Throughput Dynamic Light Scattering for Screening Biotherapeutic Formulations
BP1015-Raising-the-bar.gif
Raising the Bar for Biopharma Training
Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
William K. Oh, MD
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Novotech Named Best Australian CRO at Asia-Pacific Biopharma Excellence Awards

Patrick Lavery
March 28th 2025
Article

Winners are selected entirely through industry voting, with those honored representing recognition by their peers.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Curia Expands Sterile Fill/Finish Site in UK

Feliza Mirasol
March 20th 2025
Article

Curia plans to expand its sterile fill/finish capabilities at its Glasgow, UK, site and gives updates on an ongoing expansion at its Albuquerque, NM, site.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Avantor Presents Completed Hydration Expansion at DCAT Week 2025

Susan Haigney
March 18th 2025
Article

The company gave a first look at its completed expansion at its manufacturing site in Gliwice, Poland during DCAT Week 2025 in New York City.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

DCAT Member Companies Present Latest News to Start DCAT Week 2025

Patrick Lavery
March 17th 2025
Article

The Member Company Announcement Forum is the kickoff event of the annual DCAT Week in New York City, which is being held from March 17–20.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025

Patrick Lavery
March 17th 2025
Article

This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.

© 2025 MJH Life Sciences

All rights reserved.